Pharmaceutical Manufacturing

Deloitte report unveils $5–7 billion AI life sciences opportunity

April 4, 2024 - In a recent report by Deloitte, it has been estimated that the life sciences industry has the potential to unlock a staggering $5­–7 billion in value through the application of artificial intelligence (AI). The study indicates that almost 90% of this value can be derived from three key areas: research and development (R&D),...


More Articles

GE Healthcare’s Deal to Boost Supply of Medical Imaging Contrast Agents

by Hayden Schmidt

Last week, GE Healthcare’s Pharmaceutical Diagnostic business announced that it was re-upping its iodine deal with Sociedad Quimica y Minera de Chile (SQM). The long-term agreement will help GE...